TEZSPIRE™ (TEZEPELUMAB-EKKO) NOW AVAILABLE IN THE UNITED STATES FOR THE TREATMENT OF SEVERE ASTHMA : vimarsana.com

/PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced TEZSPIRE™ (tezepelumab-ekko) is now available for shipment to wholesalers in the U.S....

Related Keywords

Puerto Rico , United States , America , Lymphopoietin Isoforms , Michael Strapazon , Megan Fox , Murdo Gordon , Amgen , World Allergy Organization , Clinical Trial Program , Astrazeneca , Drug Administration Breakthrough Therapy Designation , Therapeutics Inc , Teneobio Inc , Most Recent National Asthma Data , Airways Of Human Asthmatics In Vivo , Centers For Disease , Kyowa Kirin Co Ltd , Tezspire Patient Assistance Program , Drug Administration , Beigene Ltd , Tezspire Together Program , Exchange Commission , Global Commercial Operations , Tezspire Patient Assistance , Important Safety Information , Asthma Symptoms , Priority Review , Orphan Drug Designation , Dow Jones Industrial Average , Best Workplaces , Great Place , Five Prime Therapeutics , Thousand Oaks , Moderate To Severe Uncontrolled , Adolescents With Severe , Uncontrolled Asthma , Stromal Lymphopoietin Isoforms , Inflammatory Disorders , Human Asthmatics In Vivo , Potential Biomarker , Severe Refractory , Disease Control , Most Recent National Asthma , Accessed September , Manag Care Spec Pharm , Med Res Opin , Recognise Asthma , Care Respir , Allergy Organization , Allergy Clin , Reducing Oral Corticosteroid Use , Adults With Oral Corticosteroid Dependent Asthma ,